Guangdong Hybribio Biotech Co.Ltd(300639) : Announcement on the progress of the selection of investment partners for the holding subsidiary’s winning the bid for the project of building a third-party medical laboratory in Nanhai District, Foshan City

Securities code: Guangdong Hybribio Biotech Co.Ltd(300639) stock abbreviation: Guangdong Hybribio Biotech Co.Ltd(300639) Announcement No.: 2022023 Guangdong Hybribio Biotech Co.Ltd(300639)

Announcement on selection of the third party of Foshan Nanhai medical laboratory project

The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions. 1、 Project overview

Guangdong Hybribio Biotech Co.Ltd(300639) (hereinafter referred to as “the company”) holding subsidiary Guangzhou Kaipu Medical Laboratory Development Co., Ltd. (hereinafter referred to as “Kaipu medical laboratory”) won the bid for the investment partner selection of the project of building a third-party medical laboratory in Nanhai District, Foshan City. For details, please refer to the company’s announcement on cninfo.com on January 12, 2022( http://www.cn.info.com.cn. )Announcement on the selection of investment partners for the construction of third-party medical laboratory project in Nanhai District, Foshan City by the holding subsidiary (Announcement No.: 2022003). 2、 Progress introduction

Recently, Kemp medical laboratory has completed the industrial and commercial establishment registration of the third-party medical laboratory involved in the project and obtained the business license issued by Nanhai District market supervision and Administration Bureau of Foshan City. The relevant registration information is as follows:

1. Unified social credit Code: 91440605ma7m4g07x

2. Name: Foshan Kaipu medical laboratory Co., Ltd

3. Type: other limited liability companies

4. Domicile: No. 14-2, Guihe Road, Lishui Town, Nanhai District, Foshan City (domicile declaration)

5. Legal representative: Xu Weiwei

6. Registered capital: RMB 50 million

7. Date of establishment: March 23, 2022

8. Term of operation: long term

9. Business scope: licensed items: Inspection and testing services; Medical services; Class III medical device business; Class III medical device leasing; Indoor environment detection; Forensic services. (for projects that must be approved according to law, business activities can be carried out only after being approved by relevant departments, and the specific business projects shall be subject to the approval documents or licenses of relevant departments) general projects: medical research and experimental development; Technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion; Ecological resources monitoring; Mechanical equipment leasing; Sales of mechanical equipment; Leasing of computer and communication equipment; Wholesale of computer software, hardware and auxiliary equipment; Retail of computer software, hardware and auxiliary equipment; Sales of electrical equipment; Sales of communication equipment; Sales of electronic products; Instrument sales; Sales of intelligent instruments; Sales of electrical instruments and meters; General equipment repair; Electrical equipment repair; Instrument repair; Repair of special equipment; Information consulting services (excluding licensed information consulting services); Engineering technical services (except planning management, survey, design and supervision); Engineering management services; Health consulting services (excluding diagnosis and treatment services); Enterprise management consulting; Socio economic advisory services; Market Research (excluding foreign-related research); Marketing planning; Consulting and planning services; Conference and exhibition services; Translation services; Remote health management services; Safety consulting services; Research and development of bio based materials technology; Sales of bio based materials; Research and development of biochemical product technology; Non residential real estate leasing; Sales of class I medical devices; Class I medical device leasing; Sales of class II medical devices; Class II medical device leasing; Software development; Network and information security software development; Software sales; Sales of information security equipment; Data processing services; Big data services; Internet data services; Data processing and storage support services; Computer system services; Information system operation and maintenance services; Information system integration service; Application system integration services in artificial intelligence industry; Import and export of goods; Technology import and export; Environmental protection monitoring. (except for the items that must be approved according to law, the company shall independently carry out business activities according to law with its business license)

It is hereby announced.

Guangdong Hybribio Biotech Co.Ltd(300639) board of directors

March 24, 2002

- Advertisment -